- Home
- NCLH vs ICUCW Comparison
NCLH vs ICUCW Comparison
Compare NCLH & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCLH
- ICUCW
- Stock Information
- Founded
- NCLH 1966
- ICUCW N/A
- Country
- NCLH United States
- ICUCW United States
- Employees
- NCLH N/A
- ICUCW 12
- Industry
- NCLH Marine Transportation
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- NCLH Consumer Discretionary
- ICUCW Health Care
- Exchange
- NCLH Nasdaq
- ICUCW Nasdaq
- Market Cap
- NCLH N/A
- ICUCW N/A
- IPO Year
- NCLH 2013
- ICUCW 2021
- Fundamental
- Price
- NCLH $16.38
- ICUCW $0.04
- Analyst Decision
- NCLH Buy
- ICUCW
- Analyst Count
- NCLH 18
- ICUCW 0
- Target Price
- NCLH $28.76
- ICUCW N/A
- AVG Volume (30 Days)
- NCLH 15.8M
- ICUCW N/A
- Earning Date
- NCLH 04-30-2025
- ICUCW N/A
- Dividend Yield
- NCLH N/A
- ICUCW N/A
- EPS Growth
- NCLH 384.69
- ICUCW N/A
- EPS
- NCLH 1.89
- ICUCW N/A
- Revenue
- NCLH $9,479,651,000.00
- ICUCW N/A
- Revenue This Year
- NCLH $9.58
- ICUCW N/A
- Revenue Next Year
- NCLH $10.63
- ICUCW N/A
- P/E Ratio
- NCLH $8.67
- ICUCW N/A
- Revenue Growth
- NCLH 10.87
- ICUCW N/A
- 52 Week Low
- NCLH $14.21
- ICUCW N/A
- 52 Week High
- NCLH $29.29
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- NCLH 37.98
- ICUCW N/A
- Support Level
- NCLH $15.85
- ICUCW N/A
- Resistance Level
- NCLH $16.63
- ICUCW N/A
- Average True Range (ATR)
- NCLH 1.33
- ICUCW 0.00
- MACD
- NCLH 0.06
- ICUCW 0.00
- Stochastic Oscillator
- NCLH 40.33
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.